DK131988A - Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur - Google Patents

Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur

Info

Publication number
DK131988A
DK131988A DK131988A DK131988A DK131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A
Authority
DK
Denmark
Prior art keywords
binding protein
dna structure
igf binding
vector containing
coding
Prior art date
Application number
DK131988A
Other languages
English (en)
Other versions
DK131988D0 (da
Inventor
Stenwert Leonard Sebastia Drop
Arend Brinkman
Original Assignee
Erasmus University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University filed Critical Erasmus University
Priority to DK131988A priority Critical patent/DK131988A/da
Publication of DK131988D0 publication Critical patent/DK131988D0/da
Priority to AU32965/89A priority patent/AU3296589A/en
Priority to PCT/NL1989/000008 priority patent/WO1989008667A1/en
Priority to JP1503492A priority patent/JPH03504494A/ja
Priority to EP89903815A priority patent/EP0404812A1/en
Publication of DK131988A publication Critical patent/DK131988A/da
Priority to DK216690A priority patent/DK216690A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK131988A 1988-03-11 1988-03-11 Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur DK131988A (da)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK131988A DK131988A (da) 1988-03-11 1988-03-11 Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
AU32965/89A AU3296589A (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
PCT/NL1989/000008 WO1989008667A1 (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
JP1503492A JPH03504494A (ja) 1988-03-11 1989-03-10 Ｉｇｆ結合タンパク質、ｉｇｆ結合タンパク質をコードするｄｎａ構造体及びこのｄｎａ構造体を含有したベクター
EP89903815A EP0404812A1 (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
DK216690A DK216690A (da) 1988-03-11 1990-09-10 Rekombinant ifg-bindingsprotein (ibp-1)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK131988A DK131988A (da) 1988-03-11 1988-03-11 Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur

Publications (2)

Publication Number Publication Date
DK131988D0 DK131988D0 (da) 1988-03-11
DK131988A true DK131988A (da) 1989-09-12

Family

ID=8103523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131988A DK131988A (da) 1988-03-11 1988-03-11 Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur

Country Status (5)

Country Link
EP (1) EP0404812A1 (da)
JP (1) JPH03504494A (da)
AU (1) AU3296589A (da)
DK (1) DK131988A (da)
WO (1) WO1989008667A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
EP0418230B1 (en) * 1988-04-12 1995-12-27 Amgen Boulder Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
WO1990000569A1 (en) * 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
CA2090703A1 (en) * 1990-08-28 1992-03-01 Michael C. Kiefer Insulin-like growth factor binding protein (igfbp-4)
CA2090702A1 (en) * 1990-08-28 1992-03-01 Michael C. Kiefer Insulin-like growth factor binding protein igfbp-5
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
EP0556344B1 (en) 1991-01-08 2003-08-13 Chiron Corporation New insulin-like growth factor binding protein
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US6420172B1 (en) 1992-04-20 2002-07-16 Tib Company, Llc Method for inducing tumor immunity
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
DE69333063T2 (de) 1992-11-04 2004-05-13 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
WO1994022466A1 (en) * 1993-04-07 1994-10-13 Synergen, Inc. Methods of using insulin-like growth factor binding proteins
PT723453E (pt) * 1993-08-03 2000-07-31 Celtrix Pharma Metodo de tratamento de desordens reprodutoras
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
DK0804562T3 (da) 1994-07-12 2003-02-10 Human Genome Sciences Inc Bindevævsvækstfaktor-2
EP0800530A4 (en) * 1994-07-20 1998-12-02 Celtrix Pharma IGF / IGFBP COMPLEX FOR PROMOTING BONE TRAINING AND REGULATING BONE REMODELING
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
IL143866A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
IL143834A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
AU2001263215A1 (en) 2000-05-16 2001-11-26 Genentech Inc. Method for treating cartilage disorders
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
DK2274978T3 (da) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Fremgangsmåder til behandling af en insulin-lignende vækstfaktor-I(IGF-I)-mangel
CA2541015A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
EA202090705A1 (ru) 2017-09-11 2020-06-11 Шайр Хьюман Дженетик Терапиз, Инк. Способы и композиции, предназначенные для лечения хронических заболеваний легких
IL301688A (en) 2020-10-19 2023-05-01 Oak Hill Bio Ltd The compositions are suitable for use in newborns
WO2023139115A1 (en) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338480A1 (de) * 1983-10-22 1985-05-02 Behringwerke Ag, 3550 Marburg Neues protein pp(pfeil abwaerts)2(pfeil abwaerts)(pfeil abwaerts)0(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung

Also Published As

Publication number Publication date
WO1989008667A1 (en) 1989-09-21
AU3296589A (en) 1989-10-05
EP0404812A1 (en) 1991-01-02
JPH03504494A (ja) 1991-10-03
DK131988D0 (da) 1988-03-11

Similar Documents

Publication Publication Date Title
DK131988D0 (da) Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
DK217889A (da) Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for desacetoxycephalosporin c synthetase
GB8628313D0 (en) Dna rna peptides/polypeptides
DE3669112D1 (de) Tourenskibindung.
DK40086A (da) Formaldehyd-bindemiddel, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK100985D0 (da) Dna, der koder for human tumornecrosefaktor, samt humant tumornecrosefaktor-polypeptid og fremgangsmaader til fremstilling heraf
NO922155L (no) Peptider og antistoffer som inhiberer integrinligandbinding
DK122687A (da) Polypeptid, dna og anvendelse deraf
DK108189A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
DK317288D0 (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK4387D0 (da) Human-praepo-insulinlignende-vaerkstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne
DK589085D0 (da) Rekombinant dna-udtrykkelsesvektor, der er funktionel og udvaelgelig iplanter
DK178386D0 (da) Rekombinant dna-udtrykkelsesvektor og dna-forbindelser, der udtrykker isopenicillin n synthetase
NO904024L (no) Heparin-bindende proteiner, dna som koder for dem, fremgangsmaater for fremstilling derav og terapeutisk preparater inneholdende dem.
DK300787D0 (da) Dna-struktur fra cytomegalivirus, ekspressionsvektor derfor samt dermed kodede proteinstrukturer og disses anvendelse
GB8404378D0 (en) Dna sequence recombinant dna molecules
DK102088A (da) Rekombinant-dna-udtrykkelsesvektorer og dna-produkter, der koder deacetoxycephalosporin c syntetase og deacetylsephalosporin c synthetase
DK606088D0 (da) Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for isopenicillin n synthetase
DK224985A (da) Peptider, og midler indeholdende peptiderne
NO842682L (no) Polypeptid og dna-sekvens samt vektor
DK221389D0 (da) Fibronectin-bindende protein og fremgangsmaade til fremstilling deraf
DK174933B1 (da) Modificeret hygromycin B-resistens DNA-sekvens samt plasmider, vektorer og transformanter indeholdende denne DNA-sekvens
DK151788D0 (da) Hybridserpiner og dna, som koder derfor
DK164877C (da) Heparinbindende protein (hbp), terapeutisk praeparat indeholdende hbp, fremgangsmaade til fremstilling af proteinet hbp samt dna-sekvens og cdna, der koder for hbp
GB8716938D0 (en) Dna sequence coding

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment